221 Anemia treatment, clinical event rates, and healthcare resource utilization (HCRU) in a US prevalent hemodialysis (HD) cohort hyporesponsive to erythropoietin stimulating agents (ESAs)
In: American Journal of Kidney Diseases, Jg. 83 (2024-04-01), Heft 4, Number 4 Supplement 2, S. S67
serialPeriodical
Zugriff:
Titel: |
221 Anemia treatment, clinical event rates, and healthcare resource utilization (HCRU) in a US prevalent hemodialysis (HD) cohort hyporesponsive to erythropoietin stimulating agents (ESAs)
|
---|---|
Zeitschrift: | American Journal of Kidney Diseases, Jg. 83 (2024-04-01), Heft 4, Number 4 Supplement 2, S. S67 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 0272-6386 (print) ; 1523-6838 (print) |
DOI: | 10.1053/j.ajkd.2024.01.224 |
Sonstiges: |
|